Загрузка...

New cast for a new era: preclinical cancer drug development revisited

Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and mortality in patients with cancer. However, despite an urgent need for more effective anticancer compounds, current preclinical drug evaluations largely fail to satisfy the demand. New preclinical strategies,...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Herter-Sprie, Grit S., Kung, Andrew L., Wong, Kwok-Kin
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2013
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754257/
https://ncbi.nlm.nih.gov/pubmed/23999436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI68340
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!